Stay updated on Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial
Sign up to get notified when there's something new on the Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial page.

Latest updates to the Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial page
- Check3 days agoChange DetectedA new Revision: v3.3.4 was added to the Record History and Revision: v3.3.3 was removed.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedLatest history entry shows Revision: v3.3.3 added; HHS Vulnerability Disclosure and Revision: v3.3.2 removed from the footer.SummaryDifference0.1%

- Check53 days agoChange DetectedThe version history shows internal revision updates with v3.3.2 added and v3.2.0 removed, which do not affect trial data or public content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedThe site-wide government funding/operating status notice has been removed from the page header. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check74 days agoChange DetectedOn 2025-10-29, the record was updated to include a Results Posted entry, adding the Results, Outcome Measures, and Study Status details. The 2025-07-08 entry for 'Results Submitted' was removed, and the 2025-10-15 version 36 consolidates these updates.SummaryDifference0.5%

- Check103 days agoChange DetectedMajor change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).SummaryDifference10%

Stay in the know with updates to Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial page.